Camurus AB (publ)(7CA)

Description: Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain and Brixadi to treat opioid use disorder. Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; and Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity, as well as licensing agreement with Solasia Pharma. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden. The company operates as a subsidiary of Sandberg Development AB.

---

Keywords: Biopharmaceutical Prostate Cancer Chemotherapy Clinical Trial Obesity Chronic Pain Pulmonary Arterial Hypertension Ethers Treatment Of Prostate Cancer Drug Rehabilitation Opioid Use Disorder Neuroendocrine Tumors Acromegaly Buprenorphine Camurus Chemotherapy Induced Nausea Semisynthetic Opioids Naltrexone Treatment Of Opioid Use Disorder Hydroxyarenes Kappa Opioid Receptor Antagonists Buvidal Cam2029 Cam2032 Cam2043 Cam2047 Cam4071 Endocrine Disorder Genetic Obesity Disorders Polycystic Liver Diseases Rare Genetic Disorders Raynaud Severe And Chronic Conditions Treatment Of Endocrine Disorder Treatment Of Genetic Obesity Disorders Treatment Of A Range Of Rare Genetic Disorders

---

Home Page: www.camurus.com

Ideon Science Park
Lund, 223 70
Sweden
Phone: 46 4 62 86 57 30

---

Officers

Exchange: F

Country: DE : Germany

Currency: Euro (€)